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The T1P1 strain of Japanese encephalitis (JE) virus was recently isolated from paddy-free Liu-Chiu Islet in which natural
JE antibody has been prevalent. In mouse neuroblastoma-derived Neuro-2a cells, T1P1 appeared significantly lower in virus
productivity than another local isolate, CH1392. It implied that this new isolate possesses a characteristic viral replication
pattern other than that of CH1392. T1P1 has also shown lower neurovirulence, which was reflected by a significantly higher
LD50 (2.44 3 10
6 PFU) than CH1392 (2.87 3 102 PFU). In comparison of the full-length RNA sequences between T1P1 and
CH1392, a total of 7 nucleotides, including 1 in preM/M and 2 each in NS3, NS5, and the 39-end noncoding region (NCR),
appeared different. Of them, only the changes in NS3 (position 325, T for CH1392, A for T1P1; and position 364, G for CH1392
and A for T1P1) resulted in substitutions of deduced amino acids. There were two additional nucleotide changes appearing
in the 39-NCR. The amino acids 109 Phe and 122 Glu in NS3 of CH1392 were substituted by Ile and Lys, respectively, in T1P1.
The unique growth properties and low virulence of T1P1 presented in this report were likely related to abnormal enzymatic
activity due to mutations of the NS3 gene (especially position 364) and possibly to the mutations in the 39-NCR. The natural
attenuation of T1P1 that has been circulating in paddy-free Liu-Chiu Islet may account for the absence of clinical JE cases
in past years. © 2001 Academic Press
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The distribution of Japanese encephalitis (JE) is wide-
spread throughout most of Asia, from the southeastern
ex-USSR in the north to Indonesia in the south (Rosen,
1986) and even farther to Papua New Guinea and Aus-
tralia as well (Mackenzie, 1999). Although JE virus infec-
tions with clinical symptoms are relatively rare, the case
fatality rate can be as high as 20–40%. Furthermore,
about 15–50% of the survivors may end up with various
sequelae, including persistent neurologic impairment
and mental retardation (Monath, 1990). Mass vaccination
has been implemented in Taiwan since 1968; however,
there still are 20–30 clinical cases reported annually
(Huang et al., 1996; Wu et al., 1999).
The etiologic agent of JE is one of about 70 members
of the genus Flavivirus, which belongs to the family
Flaviviridae (Monath and Heinz, 1996). Like other flavivi-
ruses, the genome of JE virus is a single-stranded, pos-
itive-sense RNA ;11K nucleotides in length and con-
tains a single open reading frame of a polyprotein (Su-
miyoshi et al., 1987; Chambers et al., 1990). In general,
Nucleotide sequences described in this report have been deposited
with GenBank under Accession Nos. AF254452 (for strain CH1392) and
AF254453 (for strain T1P1).1 To whom reprint requests should be addressed. Fax: 1886 (3)
328-3031. E-mail: wjchen@mail.cgu.edu.tw.
129RNA genomes of flaviviruses evolve rather rapidly, which
somewhat reflects strategies of adaptation to their hosts
(Rice et al., 1985). In the evolutionary process of the virus,
a number of nucleotide changes may not really result in
substitution of deduced amino acids and eventually lead
to silent mutation. In contrast, some nucleotide changes
can affect phenotypic characteristics of the virus such as
antigenicity, pathogenicity, virulence, persistence, inter-
actions between the virus and host cells, and so forth
(Nitayaphan et al., 1990; Huong et al., 1993; Ni and
Barrett, 1996; Chung et al., 1996; Wu et al., 1998; Man-
gada and Takegami, 1999). Molecular data based on
sequences of a 240-bp cDNA fragment amplified from
the prM gene have divided Asian strains of JE virus into
four genotypes; such genetic variations may occur
among strains isolated from different time periods in the
same geographic region (Chen et al., 1990, 1992).
JE virus in Taiwan is mostly transmitted between ver-
tebrates by mosquito vectors, including Culex tritaenio-
rhynchus, C. annulus, and C. fuscocephala, that primarily
breed in rice fields (Hsu et al., 1978). However, we re-
cently isolated the virus from another potential mosquito
vector, Armigeres subalbatus, collected from Liu-Chiu
Islet—an unconventional ecosystem for Japanese en-
cephalitis in Taiwan (Chen et al., 2000). Although there is
no question about the circulation of JE virus in this
paddy-free islet, clinical JE cases have not been reported
0042-6822/01 $35.00
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130 CHIOU AND CHENfor decades. One explanation is that the circulating virus
could be less virulent. In this study, we have compared
two strains, the new isolate T1P1 strain and another
local strain (CH1392) that was isolated from C. tritaenio-
rhynchus collected in central Taiwan in 1990, in virus
replication, virulence, and genomic sequences. The as-
sociation of an existing naturally attenuated strain with
the absence of clinical JE infections in Liu-Chiu Islet is
also discussed in this report.
RESULTS
Full-length sequence of viral genomes in nucleotides
and deduced amino acids
The full-length nucleotide sequences have been ob-
tained from reverse transcriptase-polymerase chain re-
action (RT-PCR) products derived from T1P1 and CH1392,
respectively. The sequences can be accessed from Gen-
Bank under Accession Nos. AF254452 for CH1392 and
AF254453 for strain T1P1. A total of 7 different nucleo-
tides were shown in the genome of T1P1 in comparison
with CH1392 (Table 1). Of them, nucleotide 954 (202 in
preM/M; C in T1P1 and U in CH1392) was the only base
different in this region between the two strains. This
nucleotide change did not result in substitution of any
deduced amino acid. In nonstructural genes, 2 nucleo-
tides each occurred in NS3 and NS5, respectively. Dif-
ferences in NS3 included nucleotides 4932 (position 325
in NS3) and 4971 (position 364 in NS3). The former was
the transition of A (for T1P1) to U (for CH1392) while the
latter was the transversion of A (for T1P1) to G (for
CH1392). Both changes of nucleotide were somewhat
adjacent to the 39 end of NS2B gene. At the level of
deduced amino acids in NS3, the change of nucleotide
325 has resulted in the substitution of Phe (for CH1392)
by Ile (for T1P1) at amino acid 109, whereas nucleotide
T
Genomic Differences of Nucleotides (nt) and Amino
Location of
changed nta
Changed ntb
T1P1 CH1392
954 CUG UUG
4932 AUC UUC
4971 AAG GAG
7682 AGA AGG
9929 UGU UGC
10438 A G
10523 A G
a The location of the changed nucleotide in the whole virus genome
b Bold letters represent nucleotide differences between the two stra
c 39-NCR, 39-end noncoding region of the viral genome.364 resulted in the substitution of Glu (for CH1392) by Lys
(for T1P1) at amino acid 122 (Table 1).Changes in NS5 affected nucleotides 7682 (position 6
in NS5; A for T1P1 and G for CH1392) and 9929 (position
2253 in NS5; U for T1P1 and C for CH1392). Neither of
them resulted in the substitution of deduced amino acids
and eventually were silent mutations. There also were
two nucleotides changed in the 39 noncoding region
39-NCR), at nucleotides 10438 (position 47 in 39-NCR)
nd 10523 (132 in 39-NCR). Both nucleotide changes
ere the transversion mutation of A (for T1P1) 7 G (for
H1392).
irus growth in mouse neuroblastoma Neuro-2a cells
The growth of mouse neuroblastoma-derived Neuro-2a
ells infected by either T1P1 or CH1392 was similar;
owever, the growth was somewhat limited after 30 h p.i. in
omparison with uninfected cells (Fig. 1A). The infection
ates of cells inoculated by both virus stains were low.
nly 4.7% of Neuro-2a cells were infected by T1P1,
hereas 35.8% of CH1392-infected cells appeared at 48 h
.i. (Table 2).
For titer changes during the course of infection,
euro-2a cells inoculated by either strain of JE virus did
ot show detectable antigen (detected by indirect immu-
ofluorescence antibody test (IFA)) until 10 (for CH1392)
r 12 (For T1P1) h p.i. In addition, T1P1 was less produc-
ive than CH1392 in Neuro-2a cells; the virus yield was as
ow as 5.0 3 101 PFU/ml for the extracellular titer at 5 h
p.i.; the titer at 42 h p.i. increased to 2.35 3 106 PFU/ml.
For CH1392, the titers observed at the same time points
were 5.0 3 101 and 1.02 3 107 PFU/ml, respectively (Fig.
B). The growth trend for the intracellular titers was
elatively similar to that observed for the extracellular
iters. The intracellular titer for CH1392 was 6.6 3 101
PFU/ml at 5 h p.i. while the peak titer reached at 36 h p.i.
was 1.43 3 106 PFU/ml; the titers were 5.0 3 101 PFU/ml
5
(aa) between T1P1 and CH1392 Strains of JE Virus
Substituted aa
Encoded protein
(aa location)P1 CH1392
Leu M
Phe NS3 (109)
Glu NS3 (122)
Arg NS5
Cys NS5
oding Noncoding 39-NCRc
oding Noncoding 39-NCRABLE 1
Acids
T1
Leu
Ile
Lys
Arg
Cys
Nonc
Nonc
.at 5 h p.i. and 4.5 3 10 PFU/ml at 42 h p.i. for T1P1
(Fig. 1C).
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131NS3 MUTATIONS OF JE VIRUS AND NATURAL ATTENUATIONNewly synthesized virus RNA detected from mouse
neuroblastoma Neuro-2a cells
RNA synthesis has been seen in Neuro-2a cells inoc-
ulated with either T1P1 or CH1392 strain of JE virus.
FIG. 1. Virus growth in mouse neuroblastoma-derived Neuro-2a cells.
(A) Growth trend of Neuro-2a cells inoculated with T1P1 or CH1392 in
comparison with uninfected cells. (B) Extracellular virus titers of T1P1
and CH1392 produced in Neuro-2a cells which were inoculated with
either strain of the virus. (C) Intracellular virus titer of T1P1 and CH1392
produced in Neuro-2a cells which were inoculated with either strain of
the virus.Detection of both positive- and negative-sense RNA syn-
thesis by RT-PCR from Neuro-2a cells infected by either
fvirus strain during the period of 24 h p.i. is shown in Fig.
2. Enhanced synthesis of positive virus RNA appeared at
10 h p.i. for T1P1, whereas it was at 8 h p.i. for CH1392
(Fig. 2A). Similarly, negative-sense viral RNA gradually
increased along with the time, which can be seen at 15 h
p.i. for T1P1, whereas it appeared as early as 10 h p.i. for
CH1392 (Fig. 2B).
Neurovirulence of JE virus and its growth in suckling
mice
Viral neurovirulence was evaluated in suckling mice
and was expressed by the 50% lethal dose (LD50). The
esults showed that the LD50 of CH1392 was 2.87 3 10
2
PFU while that of T1P1 was 2.44 3 106 PFU, suggesting
that CH1392 was significantly more neurovirulent than
T1P1.
To determine growth efficiency of the virus in mouse
brains, a separate experiment was carried out in three
groups of suckling mice by inoculation with 1 3 102 or
1 3 106 PFU/mouse of T1P1 or 1 3 102 PFU/mouse of
CH1392 (Table 3). In the group inoculated with the dos-
age of 1 3 102 PFU/mouse of CH1392, the virus became
detectable (log 2.92; 8.3 3 102 PFU/g brain weight) at day
p.i., whereas the titer increased to the peak at day 3 p.i.,
hich was log 5.39 (1.28 3 105) PFU/g brain weight.
owever, no virus titer was detected from the mouse
rain inoculated with the dosage of 1 3 102 PFU/mouse
f T1P1 throughout the course of observation. In the
roup inoculated with 1 3 106 PFU/mouse of T1P1, the
irus titer (log 3.65; 4.42 3 103 PFU/g brain weight)
became detectable as early as 1 day p.i., which in-
creased to log 9.39 (3.52 3 109) PFU/g brain weight at
day 6 p.i. Clearly, T1P1 was less efficient in replication
than CH1392 unless a high dosage of the virus (i.e., 1 3
106 PFU/mouse in this case) was inoculated into the
rain of tested suckling mice.
TABLE 2
Infection Ratesa of Mouse Neuroblastoma Neuro-2a Cells Separately
Inoculated with the T1P1 or CH1392 Strain of JE Virusb
Hours
postinoculation
Infected Neuro-2a cells (%)
T1P1 CH1392
6 0 0
8 0 0
10 0 1.5 6 0.5
12 ,1 3.0 6 1.0
24 ,1 12.5 6 5.0
48 4.7 6 3.9 35.8 6 8.8
a About 50 cells from a field under a light microscope were counted
or evaluation of positive rates with triplicates.
b Multiplicity of infection 5 5.
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132 CHIOU AND CHENDISCUSSION
T1P1 JE virus has been known to circulate in Liu-Chiu
slet, which is paddy-free, but clinical infection is absent
Ku, unpublished data; Chen et al., 2000). This new iso-
ate produced significantly lower virus yield when it was
rown in mouse neuroblastoma-derived Neuro-2a cells
n comparison with another local strain, CH1392. Looking
FIG. 2. Newly synthesized viral RNA from mouse neuroblastoma-d
detecting positive-sense viral RNA from Neuro-2a cells infected with e
in T1P1-infected cells (left), whereas it was 8 h p.i. in CH1392-infected
cells infected with either T1P1 or CH1392. Detectable level of newly syn
it was seen as early as 10 h p.i. in CH1392-infected cells (right). M, 10
T
JE Virus Titersa (Log10 PFU/g Brain Weight) Produced in Suckling M
Virus strain
inoculated
Inoculated
PFU/mouse Day 1 Day
CH1392 1 3 102 ,1 2
T1P1 1 3 102 ,1 ,1
T1P1 1 3 106 3.65 5a The virus titer was determined from three inoculated mice using plaque a
b Each mouse was inoculated with 10 ml of diluted virus suspension.t the velocity of RNA synthesis in infected Neuro-2a
ells, T1P1 was also slower (4 h later for negative-sense
NA synthesis) than CH1392. Virus growth was clearly
ifferent between these two strains of JE virus (Hase et
l., 1989).
T1P1 showed a higher LD50 (2.44 3 10
6 PFU) in com-
arison with CH1392 (2.87 3 102 PFU), indicating that
Neuro-2a cells during a time course of 24 h. (A) RT-PCR product by
P1 or CH1392. Enhanced synthesis of viral RNA appeared at 10 h p.i.
ight). (B) Negative-sense viral RNA detected by RT-PCR from Neuro-2a
d viral RNA was seen at 15 h p.i. in T1P1-infected cells (left), whereas
NA ladder. Arrow indicates the PCR product (646 bp).
tracranially Inoculated with Different Dosages of T1P1 or CH1392
Log10 titer of virus yield post inoculation
Day 3 Day 4 Day 5 Day 6
5.39 3.16 2.8 4.53
,1 ,1 ,1 ,1
6.72 9.54 9.86 9.39erived
ither T1
cells (rABLE 3
iceb In
2
.92
.49ssay on BHK-21 cells.
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133NS3 MUTATIONS OF JE VIRUS AND NATURAL ATTENUATIONT1P1 was relatively lower in neurovirulence. It was con-
sistent with the result of Wu et al. (1998) that CH1392 was
higher in neurovirulence than the other eight local JE
virus strains in Taiwan. As a result, the absence of
clinical cases in Liu-Chiu Islet could be attributed to the
natural attenuation of T1P1, which was likely derived
from genetic alterations after a long process of transmis-
sion in nature (Mangada and Takegami, 1999). It has
been reported that a total of 13 amino acid substitutions
in the E protein of yellow fever virus were related to virus
attenuation (McMinn, 1997). In fact, even one single
amino acid substitution can be enough to change virus
phenotypes, such as virus entry, conformation of the
receptor-binding site, or neurovirulence (Nitayaphan et
al., 1990; Cao et al., 1995; McMinn et al., 1995; Rey et al.,
995; Chung et al., 1996). Specifically, genetic change
with respect to the substitution at amino acid 138 from
Glu to Lys has been known to reduce neurovirulence of
JE virus (Sumiyoshi et al., 1995), while the substitution
ccurring at amino acid 52 from Gln to Arg or Lys can
ause delayed penetration into host cells and reduced
irulence (Hasegawa et al., 1992).
Mutations in the E gene are frequently involved in the
athogenesis of flaviviruses, especially defining tropism
nd determining virulence (Ng and Lau, 1988; Zanotto et al.,
996). In this study, nucleotide sequences of the E gene in
1P1 and CH1392 were identical though their growth prop-
rties in Neuro-2a were apparently different. The role of the
gene in this case could be trivial in determination of virus
rowth since both strains of the virus showed no difference
n the ability of the virus to enter into host cells (data not
hown). On the other hand, differences of nucleotides that
ave reflected two amino acid substitutions, including
he7 Ile at position 109 and Glu7 Lys at position 122 in
S3, may have played a relatively important role during
irus replication as this protease is involved in RNA repli-
ation of flaviviruses by mediating cleavages of some sites
n nonstructural protein precursors (Edward and Takegami,
993; Ni et al., 1995; Ryan et al., 1998; Brinkworth et al.,
1999). In fact, mutations in NS3 may also affect its function
as a helicase (Koonin, 1991) or a polymerase (Raviprakash
et al., 1998). According to a mutational analysis on the
dengue NS3, only 11 of 46 (;24%) single amino acid sub-
stitutions have yielded wild-type levels of protease activity
(Valle and Falgout, 1998), suggesting the significance of
NS3 in the replication of flaviviruses (Nunes Duarte dos
Santos et al., 2000). In mice infected by Murray Valley
encephalitis virus, clinical symptoms were seen only when
virus titers produced in the central nervous system sur-
passed ;107 PFU/g (McMinn et al., 1996). It revealed that
fficient virus replication depending on normal functions of
S3 is essential in determining viral virulence. Of mutations
n NS3 of T1P1, the change at nucleotide 4971 (A 7 G)
eems to play a more important role since it was differentrom that in all strains mentioned by Williams et al. (2000).
NS5 has been reported to be important in RNA syn-hesis as it is known to function as an RNA-dependent
NA polymerase of flaviviruses (Bartholomeusz and
right, 1993; Edward and Takegami, 1993). However,
nly 2 nucleotides changed in NS5 of T1P1 and both of
hem led to silent mutations so that they were probably
ot that critical in virus growth in this case. In the 39-NCR,
here also were two nucleotide differences between
1P1 and CH1392. The changed nucleotide (A 7 G) in
1P1 was different from most JE viruses mentioned by
illiams et al. (2000). Genetic variations including dele-
ions of variable nucleotides have been seen in the
9-NCRs of dengue viruses and JE viruses (Nitayaphan et
l., 1990; Jan et al., 1996; Shurtleff et al., 2001). Although
ariation in the 39-NCR was not seen to correlate with
engue pathogenesis (Shurtleff et al., 2001), the possible
effects of these mutations remain to be clarified in JE
virus (Jan et al., 1996).
Usually, RNA viruses, including flaviviruses, mutate
faster due to a lack of efficient proofreading or mismatch
repair system in their genomic RNA (Ruiz-Jarabo et al.,
2000). Selection from quasispecies-derived mutations
during the process of flavivirus evolution in one re-
stricted area may form a genetically divergent strain
(Rico-Hesse, 1990; Bielefeldt-Ohmann and Barclay, 1998;
Levin et al., 1999; Ruiz-Jarabo et al., 2000; Shurtleff et al.,
2001). Thus, T1P1 was likely generated after a long
period of transmission under selective pressures re-
stricted in such an isolated and paddy-free islet (Rice et
al., 1985; Levin et al., 1999; Chen et al., 2000; Williams et
al., 2000). In fact, different virulence of tick-borne enceph-
alitis virus has been seen in geographically divergent
strains (Mavtchoutko et al., 2000). There seems to be a
correlation between the geographical and genetic dis-
tances in flaviviruses (Zanotto et al., 1996).
In conclusion, T1P1 that has been circulating in Liu-
Chiu Islet is probably a naturally attenuated strain that
may be related to alterations of NS3 (especially the
nucleotide at position 4971) and possibly of 39-NCR.
Thus the absence of clinical JE cases in this paddy-free
ecosystem could be attributed to silent infections by the
attenuated T1P1. A high level of virus yield of T1P1 has
been obtained in inoculated Vero cells (data not shown).
As a consequence, this new isolate of JE virus could be
expected to be one candidate for a live-attenuated vac-
cine that may provide higher efficacy and fewer allergic
side effects in comparison with the currently used for-
malin-inactivated vaccine (Yu et al., 1962; Eckels et al.,
1988; Ku et al., 1994; Shyu et al., 1997).
MATERIALS AND METHODS
Viruses and cell cultures
Two local strains of JE virus, T1P1 and CH1392, were
used in this study. The former was isolated in 1997 from
Liu-Chiu, an unconventionally paddy-free islet (Chen et
u
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134 CHIOU AND CHENal., 2000), whereas the latter, which was used as the
reference strain, was isolated in 1990 from central Tai-
wan by the Center for Disease Control of Taiwan (for-
merly National Institute of Preventive Medicine). Both
strains were propagated in C6/36 cells and titrated with
BHK-21 cells. To maintain the cell culture, minimum es-
sential medium (GIBCO, U.S.A.) containing 10% fetal bo-
vine serum (FBS) was used and prepared as per our
previous description (Chen et al., 2000). The C6/36 cells
sed in this study were grown in a closed system at
8°C while all mammalian cells, including BHK-21 and
euro-2a (derived from mouse neuroblastoma) cells,
ere grown at 37°C with 5% CO2 atmosphere.
laque assay
A total of 1 3 105 BHK-21 cells were seeded in each
well of 24-well plates and incubated at 37°C for 3 days.
The virus samples, including culture fluid (for extracellu-
lar virus titer) and supernatant of centrifuged homoge-
nates derived from infected cells (for intracellular virus
titer) or mouse brains, were serially diluted 10-fold with
fresh culture medium containing 5% FBS before the as-
say. Seventy microliters of diluted viral suspension was
added to each well, then incubated for 1.5 h at 37°C with
gentle shaking every 15–20 min for adsorption. Monolay-
ers formed in each well were overlaid with 0.5 ml of 1.1%
methyl cellulose (Sigma, U.S.A.) in culture medium con-
taining 2% FBS and fixed with 10% formaldehyde for 30
min after incubation for 4 days at 37°C, followed by
staining with 1% crystal violet for 15 min. The virus titer
was then calculated and expressed as PFU/ml.
Kinetics of virus titer in cultured cells
Neuro-2a cells were used to monitor the kinetics of
virus growth in this study; the cells used for the test were
inoculated with either T1P1 or CH1392 at multiplicity of
infection of 5. After 1.5 h of adsorption at 37°C, cells were
washed with phosphate-buffered saline (PBS; pH 7.3)
three times, and then the cell density was adjusted to
1 3 105 cells/ml with culture medium. Cells were trans-
erred into a glass test tube and incubated at 37°C.
hree tubes containing cultured cells were collected at
-h intervals. The culture fluid in each tube was used for
irus titration. Cells adherent on the surface of the tube
ere washed with PBS, then harvested by trypsinization
fter an appropriate amount of culture medium was
dded into the tube. The cell density was determined by
he trypan blue exclusion method to measure cytopathic
ffect. Presence of viral antigens was detected by IFA,
hich was used to determine the infectivity of the
irus. For titration of intracellular viruses, the cells were
reated three times by freezing and thawing to release
ell contents.ndirect immunofluorescence antibody test
The approach to IFA followed our previous description
Chen et al., 2000). Briefly, cells from the above cultures
ere smeared onto wells of 12-well Teflon-coated slides,
ir dried, and then fixed in cold acetone (220°C) for 10
in. One drop of monoclonal antibodies specific to the
E virus (TropBio, Australia) was added onto the wells.
lides were washed with PBS after they had been incu-
ated at 37°C for 30 min, goat anti-mouse IgG antibody
onjugated with fluorescein isothiocyanate (Sigma) was
ubsequently added to the wells. Slides were washed in
BS again after another incubation under the same con-
itions. Slides were mounted with a mixture of PBS and
lycerol (3:7) and then examined under an epifluores-
ence microscope (Olympus BX50, Tokyo, Japan).
everse transcriptase-polymerase chain reaction and
ucleotide sequencing
Detection or amplification of viral RNA by RT-PCR
ollowed the protocol for RNA extraction described in the
IAamp viral RNA handbook (Qiagen, Germany). A total
f 21 primer pairs designated from published sequence
ata were used in this study to edit the full-length se-
uence of the virus genome (Nitayaphan et al., 1990). To
equence the 59- and 39-end noncoding regions, the
ragment cgatacgaattg was added to the first sense
rimer and the fragment cgatacgaattg was added to the
ast complementary primer (Jan et al., 1996). The reaction
ettings for RT-PCR were described in our previous re-
ort (Chen et al., 2000). The amplified cDNA fragments
ere run by electrophoresis on a 2% (w/v) agarose gel
ontaining 10 ml ethidium bromide (1 mg/ml in RNase-
free water) as soon as PCR cycles were completed. The
band patterns on the gel were photographed by a Po-
laroid camera upon a UV-illuminated board. For genomic
sequencing, the band corresponding to the DNA frag-
ment of interest was excised and purified by using the
Viogene gel extraction kit (Viogene, CA). It was then
sequenced directly with the RT-PCR primers or the Ap-
plied Biosystems kit (Foster City, CA, USA). All proce-
dures using the Prism automated DNA sequencing kit
followed the instructions provided by the manufacturer.
Monitoring RNA synthesis
Synthesis of viral RNA including positive and negative
strands in a time course was monitored and detected by
RT-PCR as described above. Virus RNA was extracted
from Neuro-2a cells inoculated with either T1P1 or
CH1392 of JE virus at m.o.i. 5 5. The inoculated cells
were harvested at 2, 4, 6, 8, 10, 12, 15, 18, 21, and 24 h p.i.
during the time course for monitoring RNA synthesis. The
primer pair consisting of the sense primer GGAAGTGCT-
CAACGAGACC (8795–8812) and the complementary
primer CGGTCTTTCCTTCTGCTG (9433–9450) was cho-
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135NS3 MUTATIONS OF JE VIRUS AND NATURAL ATTENUATIONsen as the marker indicating newly synthesized RNA of
either strand. However, either the complementary primer
or the sense primer was used as the first primer in the RT
step to detect synthesis of positive-strand RNA or neg-
ative-strand RNA, respectively. An additional incubation
at 94°C for 10 min followed by overnight at room tem-
perature was applied between the steps of RT and PCR
to inactivate the RTase. To detect negative-strand RNA
we used the complementary counterparts of the above
primer pair. A 646-bp amplified cDNA fragment was then
identified by running the PCR product on a 2% (w/v)
agarose gel.
Neurovirulence test
ICR suckling mice 24–48 h of age (purchased from
National Yang Ming University) were used in this study.
To determine neurovirulence, virus samples were seri-
ally diluted 10-fold with PBS to make concentrations of
103–1010 PFU/ml. Then 10 ml virus suspension of various
dilutions was intracerebrally inoculated into each mouse
brain with 27-gauge needles (Top Syringe, Tokyo, Japan).
The control group of mice was inoculated with 10 ml PBS.
total of 10–15 suckling mice were used for the test for
ach concentration of prepared virus suspension. Clini-
al symptoms, including paralysis, body balance, and
onvulsions, appeared after inoculation and were moni-
ored daily. The mortality rate of each inoculated group
as daily recorded for at least 2 weeks. Death of mice
ccurring within 48 h postinoculation was considered as
result of causes other than viral infection and was not
ncluded during data analysis. Viral neurovirulence was
xpressed as the LD50 based on the mortality rate,
counted at day 6 postinoculation, of tested suckling mice
via probit analysis (Chi, 1997).
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